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ABSTRACT
Neonatal Abstinence Syndrome (NAS) in the infant are severe symptoms from opioid
exposure in utero. These symptoms include: “central nervous system irritability, autonomic overreactivity, and gastrointestinal tract dysfunction” (Ko et al., 2016). The treatment for NAS can be
a combination of drug therapy and non-pharmacological interventions, but a standardized
treatment is lacking. A review of this literature aims to evaluate the available interventions that
lead to decreased symptom severity, reduction of length of hospital stay, and a reduction in the
use of drug therapy. As a result of the literature review, the nurse researcher supports the
standardization of treatment and consistent use of non-pharmacological interventions by nurses
to reduce withdrawal symptoms and as an adjunct to drug therapy.
This author recommends future research to be used to understand how consistently NICU
nurses use non-pharmacological interventions. A question arose from the literature review: What
are the most common non-pharmacological interventions used by NICU nurses as part of their
institutional protocols? A pilot study with a mixed-methods approach will analyze how NICU
nurses around the San Francisco (S.F.)Bay Area implement their facility’s NAS protocols. The
nurse research will create a survey with open-ended and closed-ended questions. Furthermore, it
will be analyzed using descriptive and content analysis. The study will intend to help nurses in
three ways: practice effective and consistent non-pharmacological interventions, increase
confidence in caring for newborns affected by NAS and be acquainted with protocols among Bay
Area hospitals.
Key Words: neonatal abstinence syndrome, morphine, cuddling, rooming-in, volunteer, and
standardization.
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INTRODUCTION
The use of prescription and illicit opioids in the United States (U.S.) is a growing burden on
the healthcare system. Within a short period, “the number of women with opioid use disorder at
labor and delivery more than quadrupled” (Ko, Haight, Tong, Bohm & Callaghan 2018 pg. 845).
This rise of opioid use disorder has risen due to the excessive prescriptions and the challenges in
accessing treatment to control pain (Ko et al.). The misuse of opioids during pregnancy leads to
poor prenatal care, which results in preterm birth, low birth weight (LBW), neonatal abstinence
syndrome (NAS), and respiratory depression (Feder, Letourneau, & Brook, 2018 pg.1). The
characteristics of NAS can vary depending on the woman’s gestational age and other factors that
can increase the severity of symptoms.
Problem Statement
Opioid use during pregnancy can have detrimental effects, making this topic valuable to
nursing practice. The rising incidence of NAS has prompted many healthcare professionals to
develop different care methods for the newborn. Nurses are at the forefront of care for infants
with NAS. Nurses need to know what other treatments are available for their patients. They also
need to understand how to optimize outcomes for neonates with NAS.
Problem Question
This thesis aims to answer these questions: How do pharmacological and nonpharmacological interventions affect newborns diagnosed with neonatal abstinence syndrome?
What are the best practices to treat NAS? This literature review will evaluate care and current
practices that have shown beneficial outcomes for the newborn.
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LITERATURE REVIEW
Introduction
Neonatal Abstinence Syndrome in the neonate manifests as withdrawal symptoms from the
mother’s use of opioids during pregnancy. A review of the literature will help to understand the
treatment approaches for NAS. In this paper, the nurse researcher has reviewed six primary
articles to analyze. The purpose of the review is to evaluate neonatal abstinence syndrome
practices that lead to beneficial outcomes for the infant. This literature review was organized
under two headings: management of treatment and types of treatment. The investigation
produced many articles; therefore, the headings were subdivided into subheadings: assessment
tool, predictive factors, standardization of treatments, cuddling, drug therapy, and rooming-in.
The articles reviewed were located from Dominican University Archbishop Alemany Library
database: CINAHL and PubMed from the years ranging from 2000-2021. An attached literature
review table is added at the end of the paper. (Appendix A)

MANAGEMENT OF TREATMENT
Assessment Tool
The first step of the nursing process is an assessment which forms the basis of the care plan.
The traditional Finnegan Neonatal Abstinence Scoring Systems (FNASS) was developed in the
1970s. The infants symptoms are assessed which then a score is given and possibly
pharmacological management. Healthcare providers widely accept the FNASS tool as the gold
standard for evaluating NAS symptoms.
In a study conducted by Grossman, Lipshaw, Osborn, & Berkwitt (2018), a new tool was
developed to assess infants. This new tool will aim to evaluate the withdrawal symptoms and
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decrease the use of pharmacological treatment. The researchers of this study believed that using
the FNASS tool commonly leads to drug therapy.
The American Academy of Pediatrics (AAP) made recommendations based on research
indicating the first line of defense for NAS is to focus on non-pharmacological interventions.
Grossman et al. (2018) designed the Eat, Sleep, Console (ESC) as a non-pharmacologic
intervention for NAS. This ESC tool would assess the newborn in a less intrusive way compared
to the FNASS. The focus is to provide swaddling, on-demand feeding, and a low stimulation
environment (Grossman et al., 2018).
The study design was a retrospective comparative study (quantitative) of 50 opioid-exposed
infants. The procedure was conducted over 17 months in the well-newborn nursery. The
symptoms were managed by using the ESC approach while at the same time gathering FNASS
scores every 4 hours. The FNASS scores "were not used to guide medical decision making
regarding the initiation of pharmacological treatment" (Grossman et al., 2018 p. 2).
The ESC approach asked three critical questions: Is the infant eating more than an ounce at
each feeding? Can the infant sleep one hour or more? And can the infant be consoled within 10
minutes? If these answers were all "yes," then the infant was considered stable, and no further
interventions were necessary. If one of these questions was a "no," interventions were strongly
recommended: feeding on demand; swaddling and holding; low stimulation environment, and
parental presence.
The study results revealed that only six infants (12%) were treated with morphine using the
ESC approach, in contrast to 31 infants (62%) treated with morphine using the FNASS approach.
Overall this innovative approach reduced the use of morphine in infants and successfully reduced
the average length of stay (LOS ) in the hospital without any severe outcomes or readmissions.
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The study had some limitations, including the inability to randomly assign patients into the
FNASS group or the ESC group, causing the failure to compare the approaches’. Scoring for
FNASS by different nurses was problematic, as each nurse has a different perspective on each
infant's sign and symptoms.
The study proved that assessing infants with NAS by meeting the physiological needs of the
newborn, instead of waiting for symptoms to manifest, is a more beneficial approach. Hospitals
can lead the way by implementing this new assessment approach, leading to a guide for safe
treatment and new protocols for infants with NAS.

Predictive Factors
Since 1972, methadone, known as a fundamental treatment for opioid drug dependence, has
been used during pregnancy. In the surge of the opioid crisis, the United States approved
buprenorphine, a maintenance medication, to treat opioid addiction. In the U.S, both methadone
and buprenorphine are considered safe drugs to use to treat opioid dependence in pregnancy.
In a study conducted by Kaltenbach et al. (2012), Predicting Treatment for Neonatal
Abstinence Syndrome in Infants Born to Women Maintained on Opioid Agonist Medication, the
objective was to analyze the factors that had the potential to increase the severity of NAS while
receiving methadone or buprenorphine to treat opioid addiction.
The study design was a double-blind, double-dummy, flexible dosing, randomized clinical
trial. The factors used to identify severity included: maternal weight at delivery, estimated
gestational age, infant birth weight, delivery type, maternal nicotine use, days of maternal study
medication received, and psychotropic medication during pregnancy.
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During the clinical trials, all mothers received thorough treatment for substance abuse and
prenatal care. The participants included 131 infants, of which two became ineligible because of
unexpected death and prematurity. The procedure to monitor the severity of NAS consisted of a
nurse trained as an expert-rater. These nurses received extensive training every six months, and
they were placed in all the medical sites. The expert-rater observed symptoms and scored the
infant every four hours with a modified Finnegan scale. In participants treated for NAS (68
infants), about 53% required medication (morphine). The predictive factors such as infant weight
and nicotine use before birth increased the use of drug therapy treatment and consequently
increasing LOS.
Kaltenbach et al. ( 2012) aimed to analyze the factors that increase NAS treatment severity
while the mother is treated for opioid addiction. Researchers concluded that during the 41
months of the clinical trial, specific variables could alter treatment for opioid dependence. A high
infant birth weight increased the probability of requiring treatment. Previous studies showed a
relationship between estimated gestational age and higher infant birth weight would increase
NAS symptoms.
The total amount of morphine used to treat infants was linked with fewer maternal receipt of
study medication, consequently increasing LOS (Kaltenbach et al. 2012). The maternal mother's
exposure to nicotine (cigarettes smoked during the 24 hours before delivery) was a significant
predictor in the infant's treatment of NAS and the dose of morphine to treat NAS. The NAS
scores were higher in infants with mother's use of SSRIs (antidepressants), requiring more
significant amounts of morphine.
There were some limitations in the study, such as not examining the role that illicit opioids
have on the expression of NAS that would require medication. It was not determined how many

10

newborns received breastfeeding, and it is unknown what role breastfeeding has on NAS. The
study did not condense drug classes to make specific conclusions on the severity of NAS. Further
research is needed to examine specific SSRIs and the severity of NAS development.
This study's strength was the training of expert-raters throughout the study's entirety, resulting
in good management accuracy. This article is relevant for the guidance of treatment because it
was able to identify factors that increased the severity of NAS. This study will help develop
interventions during the prenatal period to educate mothers regarding the factors that can
increase NAS's severity. Physicians and nurses can also plan with the mother to modify factors
such as nicotine use, delivery type, and maternal weight.

Standardization of Treatments
During this opioid epidemic, it is helpful to put forward the need for standardizing treatment for
NAS. Although The American Academy of Pediatrics advises institutions to implement
standardization of treatment of NAS, “single-institution prospective studies are lacking regarding
the success of this approach”(Burnette, Chernicky, & Towers, 2019. p. 3415). In a study by
Burnette et al. (2019), researchers developed a strict NAS management protocol. The study's
objective was to analyze infant responses and LOS of neonates treated for NAS after initiating a
strictly standardized treatment protocol.
This study sample and design was a prospective cohort that collected neonatal outcome data
before and after implementing a strict NAS morphine weaning treatment protocol. The
participants were a total of 395 neonates treated for NAS during the study. The research was
conducted over 30 months, with the principal outcome being the length of stay.
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The results concluded that LOS before the institution of the protocol was 23.31 LOS days (on
233 neonates), and after the initiation of protocol, 18.17 LOS days (on162 neonates). The
difference was 5.14 LOS days less for neonates treated under the strict protocol. The
management before the strict protocol was led by the neonatologist, who determined the weaning
process. Once the strict protocol was initiated, the weaning process was driven by the Finnegan
score. This established consistency in management from the start. Another change in the strict
protocol involved the use of "PRN" for morphine. Before the change, newborns who were being
treated with morphine and did not show improvement could have morphine increase. After
initiation, morphine was given as needed, or "PRN" to reduce the number of incidents before an
increase of morphine.
This study's limitations were that many of the subjects were primarily Caucasian, and results
can vary from populations with a higher mix of African American or Hispanic races. There was
some inconsistency with the opioid used by the mothers, the most common being buprenorphine,
and others such as methadone or heroin, which can create inconsistencies with the expressions of
NAS. Although drug screening was periodically done during gestation and delivery, there is no
way of truly knowing the specific drugs or poly-substance or intermixing to interpret accurately.
The strength of this study is the collection of data that affected LOS and the large cohort
study from the same hospital. Researchers successfully implemented a strict NAS treatment
protocol that demonstrated a reduction in LOS. This study can guide hospitals to implement
standardized treatment protocols for NAS and provide better outcomes for neonates.
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TYPES OF TREATMENTS
Cuddling
The approach to initiate treatment for newborns is non-pharmacological. There is
considerable data provided by research on the different pharmacologic interventions, but a basis
is a non-pharmacological approach. "Common methods of non-pharmacological care include
swaddling, positioning, quiet and dimly lit rooms, rooming-in, skin-to-skin contact,
breastfeeding, and infant positioning" (Mangat, Schmölzer, & Kraft, 2019). In this review, the
nurse researcher chose an original study that required a volunteer cuddler. The feasibility of
implementing the program was later assessed by interviewing both nurses and volunteers.
In October 2015, a study program in Toronto, Canada, conducted by Hignell et al. (2019), was
launched to analyze the effects of cuddling infants that required treatment for NAS. The purpose
of this study was to assess the impact of cuddling infants cuddled by trained volunteers and the
effects of LOS. Researchers collected from two groups: 14 infants in the control group and nine
infants in the cuddling program.
The study was a mixed-method technique with retrospective data collection. The researchers
used the control group to measure the practicality of implementing a cuddler program. Cuddling
was introduced as a standard of care for all infants and gave infants the needed support when
families could not be present.
A group of trained volunteers were assigned to identify the need for comfort and
overstimulation. Volunteers cuddled the infants in the sitting or standing position while engaging
them with singing, reading, or talking. Newborns who could not leave the incubator due to
medical fragility were comforted by the volunteers holding them through the window of
incubators.
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The study's limitation was that it could not compare the types of opioid exposure between the
two groups. There was also an inconsistency with the amount of cuddling time each infant
received. There are significant gaps in research on specific supportive care, such as cuddling.
The study’s strength was that it produced a reduction in LOS for the intervention group by six
days compared to the control group. Although the sample size was small, the study was
conducted over two years, demonstrating the impact that cuddling has on LOS.
The implementation of this new program created data from actual experiences through
volunteers, nurses, and family members. Cuddling was an overall positive outcome for the infant
as supportive care, resulting in reduced drug therapy. Many hospitals implement a variety of
supportive care before implementing drug therapy. Current treatments such as breastfeeding,
swaddling, rooming-in, skin-to-skin, quiet and dim rooms, and soothing techniques can be
implemented while cuddling the infant.
Drug Therapy
There are various pharmacological treatments for NAS, but for this review, the nurse
researcher chose the most common: methadone and morphine. In a Comparison of Safety and
Efficacy of Methadone vs. Morphine for Treatment of Neonatal Abstinence Syndrome (Davis et
al., 2018), the researcher's objective was to identify which medication was more effective in the
treatment of NAS.
The sample population included 117 infants in a randomized, quantitative, double-blind,
intention-to-treat clinical trial. Mothers treated for substance abuse qualified to have their infant
be randomly treated with morphine or methadone for pain control. The FNASS was used for
assessing the infants’ symptoms every four hours. The treatment protocol, which lasted 25
months, implemented drug therapy if the infant scored eight or higher two consecutive times on
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the FNASS. A one-time score of 12 higher would also initiate drug therapy. Researchers
randomly assigned methadone every 8-hours or morphine every 8-hours, with an additional
placebo alternating every 4 hours between opioid treatment. The study team also implemented
the use of phenobarbital if the infant did not respond to treatment after morphine had been
increased. Although, phenobarbital was not considered part of the study.
Once the infant obtained a lower Finnegan score (generally <8), weaning from methadone or
morphine was initiated by 10% every 12-48 hours. Once the infants' dosage reached 20% of the
initial dose, treatment was stopped, and they were observed for 48 hours before discharge.
The researchers acknowledged that they did not meet the recruitment goal for three reasons.
First, there was a 14-month delay in the study due to the development of the protocol. Secondly,
mothers declined to enroll infants because they were also treated with methadone for maternal
opioid addiction. Lastly, many sites began to implement non-pharmacological interventions,
which reduced pharmacological treatment.
The strengths of this study include a multisite comparison and assessing quickly and control
signs of NAS. This study showed that the use of methadone was more effective in decreasing the
LOS and the length of treatment (LOT) compared to morphine. Currently, the FDA only makes
recommendations to treat opioid dependence for pregnant mothers and not for neonates. Current
drug therapies for neonates with NAS are essential for nurses to understand the outcomes and
benefits.
Rooming-In
Nursing interventions are the actions and treatments that nurses carry to support patients in
meeting their set goals. A type of non-pharmacological intervention for NAS is the rooming-in
approach, intended to keep the newborn with their mothers during the withdrawal stage. Cree,
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Jairath, & May (2019), researchers of A Hospital-Level Intervention to Improve Outcomes of
Opioid Exposed Newborns, worked on a quality improvement project for a single site at
Wellspan Health York Hospital. The study aims to determine if non-pharmacological strategies,
such as the rooming-in approach, effectively care for the infants at risk of developing NAS and if
this approach will reduce LOS and drug therapy use. Rooming-in allows the newborn to stay
with the mothers in the hospital room throughout the initial hospitalization. They are then
provided a private room on the pediatric floor for continued care and non-separation of mother
and newborn while monitoring for NAS.
The sample size for this study included 88 infants that met eligibility requirements for
inclusion in the study. The study's design and methods were a retrospective chart review that
compared 48 infants in the control group exposed to methadone and buprenorphine in utero
before implementing the rooming-in approach. Researchers then compared 40 infants in the
intervention group with the same exposure in utero. In the intervention group, infants requiring
drug therapy were transferred to the pediatric floor for further monitoring instead of the NICU.
Before implementing rooming-in, the admission rate for NAS in the NICU was 100%. After
implementing rooming-in, the admission rate dropped to only 7.5%. The LOS decreased from 14
days to 10.1 days post-implementation. There was also a significant finding in the total length of
drug therapy, which fell from 15.98 days to 9.71 days post-implementation.
A single-center study and a small sample size present some limits to diverse populations and
settings. There was also some exclusion of tobacco and other illicit drugs in data that previous
studies have shown to increase the severity of NAS. Providers could not establish a process to
begin weaning from drug therapy which created inconsistencies in care. Newborns that required
drug therapy were admitted to the pediatric floor, but this became a challenge for mothers’ who
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were still inpatients. This challenge made it difficult for mothers’ to room with their babies.
Systematically identifying newborns at risk for NAS gave this study a strength. The staff's
willingness to change their practice and manage NAS infants helped increase the study’s quality.
Overall, rooming in the pediatric unit reduced LOS and NICU costs and allowed the mother to
care for her newborn while receiving treatment.
Rooming-in addresses the issue of care settings in hospitals across the U.S. Caring for a
newborn with NAS on a pediatric floor can be ideal. Still, rooming-in would be limited to
specific hospitals. NICU nurses are responsible for caring for infants who need more acute care,
and the study concluded that caring for infants in the inpatient pediatric floors can be safely
managed. Research has shown that skin-to-skin decreases restlessness and respiratory distress
and enhances engagement and breastfeeding while at the same time stimulating maternal-infant
bonding (Ryan, G., Dooley, J., Gerber Finn, L., & Kelly, L. 2018). By implementing the
rooming-in approach, infants can benefit from skin-to-skin contact ("kangaroo care") and
breastfeeding (if not contraindicated). Further research is needed in hospitals that do not have
pediatric units.
DISCUSSION OF LITERATURE REVIEW
While analyzing the literature, I have seen that all the studies aim to reduce the severity of
withdrawal symptoms in the newborn. Whether the treatment is in utero (for the mother) or after
birth, researchers are working toward finding the most promising approach to treat neonates
exposed to opiates. While pharmacological interventions are needed for severe symptoms, nurses
and volunteers can implement non-pharmacological interventions to reduce symptom severity.
Non-pharmacological interventions, such as feeding on demand, swaddling, and a low
stimulation environment can all also decrease the length of stay and reduce the length of drug
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treatments.
Multi-site research is needed on the most effective non-pharmacological interventions that are
used as treatment protocols. While searching for the volunteer cuddling interventions, I found a
20-year gap in research that pointed to the need for complementary interventions. There is
extensive research on drug therapy for both the mother and the infant, but non-pharmacological
interventions are lacking. The American Academy of Pediatrics recommends the standardization
of treatment for NAS, which has significantly improved neonatal response and decreased LOS
(Burnette et al., 2019). Nurses are at the forefront of care; therefore they will benefit from
understanding the initial interventions that can potentially decrease the severity of NAS.

PROPOSAL FOR FURTHER STUDY
Research Question
The purpose of this literature review was to evaluate both non-pharmacological and
pharmacological interventions for newborns affected by neonatal abstinence syndrome and the
best practices to care for them. A thorough review of the literature identified that many hospitals
practice a variety of non-pharmacological interventions. I want to identify the specific techniques
that are implemented among NICU nurses. The question I will aim to answer is: what are the
most common non-pharmacological interventions that NICU nurses practice as part of their
institutional protocols?
Rationale For Study
The purpose of this study will help to identify similarities and differences in nonpharmacological interventions among NICU nurses in the Bay Area. Identifying these
interventions will help nurses practice effectively and consistently while increasing confidence in
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caring for newborns affected by NAS. Hospitals can use this proposal to determine the
consistency or inconsistencies and generate treatment protocols for the Bay Area.
Theoretical Framework
The Theory of Comfort, developed by Katherine Kolcaba in 1990, is a framework that places
comfort in the frontline of healthcare. According to Kolcaba, comfort is found in three states:
relief, ease, and transcendence. By implementing the theory of comfort to this proposal, we can
identify both pharmacological and non-pharmacological interventions for any patient. Through
pain medications, patients can experience relief comfort. Ease of comfort is attained through the
patients’ experience of contentment, for example, the easing of anxieties. Kolcaba explains
transcendence as a state “in which patients can rise above their challenges” (2019, p. 6). In other
words, the patient reaches a point where they established a sense of comfort that cannot be
measured or understood.
Nurses can supply a variety of comfort measures for patients and families. Through the
nursing process, we can provide interventions that will address symptoms and the whole person.
The nursing process was designed to make changes according to the patient's condition. In the
care of infants with NAS, nurses will monitor and assess these changes because symptoms of
withdrawal do not immediately develop. At the same time, we can implement interventions for
the infant to decrease the severity of withdrawals. Making our little patients comfortable in every
way is the responsibility of nurses’. The theoretical framework of comfort will guide this
research.
Sample
The study population and eligibility criteria will only include registered nurses (RN’s )
working in the NICU around the Bay Area. We will use a snowball strategy to recruit nurses by
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sending out the survey through an online platform. The Likert survey will be created using
Qualtrics, which can easily circulate online through social media for further recruitment. The
sample size needed for this pilot study is 30-50 nurses or five per institution. A sample
questionnaire is provided in Appendix B.
Methods
I will use a cross-sectional mixed-methods approach to evaluate both quantitative and
qualitative effects. The study will use a Likert survey with 25 questions with closed-ended and
open-ended questions. Descriptive statistical analysis will interpret the quantitative data to find
commonality and frequency. An analysis of variance (ANOVA) will be used to compare and a
multiple regression will be applied to control for extraneous variables. For qualitative data,
content analysis will be employed to establish the relationships between certain words, themes,
or concepts. The mixed-methods design will produce a more thorough understanding of the
practices of NICU nurses.
Ethical Considerations
The ethical considerations for this study will include voluntary informed consent. The
proposal will be reviewed by the institutional review board (IRB) of Dominican University.
Nurses will also have the right to withdraw from the study at any time. Participants’ data will
remain strictly confidential on a password-protected computer. The survey will impose a burden
of time on the nurse of 15-20 minutes.
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CONCLUSION
There are numerous studies on the effectiveness of drug therapy for infants that require
treatment. The U.S. Federal Drug and Food Administration (FDA) has not approved a specific
drug therapy for infants. Nevertheless, morphine is the most commonly used drug for NAS
treatment when symptoms are not well controlled. Therefore, initiating non-pharmacological
treatment is pivotal in treating NAS to reduce symptoms, reduce the length of hospital stay, and
reduce the use of drug therapy.
The proposal for further research is intended for the specialized practices of NICU nurses. The
intention will be to understand the most effective non-pharmacological interventions that are part
of the hospital’s protocols. Novice nurses beginning in the NICU will learn many new skill-sets.
This literature review will allow both novice and experienced nurses to gain knowledge about
effective intervention so that they can implement new practices.
Preventing Neonatal Abstinence Syndrome (NAS) can only be accomplished by the mother
refraining from opiates and other drugs during pregnancy. Substance abuse disorder is a global
epidemic that requires a large-scale collaboration between public health officials, family
agencies, and advocates. In the meantime, researchers and healthcare providers will continue to
study the effects of NAS and effectively care for these infants.
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APPENDIX A: LITERATURE REVIEW TABLE 1
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APPENDIX B-Research Instrument
LIKERT SURVEY
Age: _______
Gender:_______
Ethnicity:____________
College Level:_________
Years as NICU Nurse:_______
Are you currently working at a NICU Nurse? Yes / No
If no, you are not working in a NICU, how many years has it been since you worked in
that setting? ____________years.
Directions: Please answer the following questions that most accurately reflect your
opinions.
1. In your opinion, does your place of employment successfully care for infants born with
neonatal abstinence syndrome?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]

2. Does your hospital regularly pre-screen mothers for opioid use?
0 [Strongly Disagree]
1[Disagree]
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2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
3. How often do you use the Eat, Sleep, Console (ESC) assessment tool?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
4. How often do you use the FNASS or modified Finnegan Scale assessment tool?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
5. Does your hospital recruit volunteers to help with feeding, cuddling, or consoling infants
with NAS in the NICU?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
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6. Do you believe that having volunteers would be more effective in assisting you with the
care of an infant with NAS?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
7. Do parents regularly participate in the care of infants being treated for NAS?
0 [Strongly Disagree]
1[Disagree]
2[Neither Agree or Disagree]
3[Agree]
4[Strongly Disagree]
8. If your hospital offers rooming-in for infants with NAS, can you describe the protocol for
this procedure? Please explain.______________________________________________
9. If your hospital uses the ESC approach does it effectively control withdrawal symptoms?
Please describe._________________________________________________________
10. If your hospital uses the FNASS tool does it effectively control withdrawal symptoms?
Please describe.________________________________________________________

